Biotechnology - Business Finance

Filter

Current filters:

Business Finance

Popular Filters

Gilead beats forecasts as Sovaldi sales soar

Gilead beats forecasts as Sovaldi sales soar

24-07-2014

US anti-virals specialist biotech firm Gilead Sciences has reported surging second-quarter 2014 sales…

Anti-viralsBiotechnologyBusiness FinanceBusiness FinanceChemistryFinancialFixed dose combinationGilead SciencesSovaldiTenofovir

$25 million milestone for Incyte on Japanese approval of Jakavi

$25 million milestone for Incyte on Japanese approval of Jakavi

08-07-2014

US biopharma company Incyte says it has earned a $25 million milestone payment from Swiss drug major…

BiotechnologyBusiness FinanceBusiness FinanceFinancialIncyteJakaviJapanMajorMedicineNovartisOncologyRegulationRuxolitinib

Vertex leaps on positive Ph III results with lumacaftor

Vertex leaps on positive Ph III results with lumacaftor

24-06-2014

US biotech firm Vertex Pharmaceuticals saw its share price rocket nearly 52% to $101.20 in extending…

BiotechnologyBusiness FinanceCystic fibrosisHealth Medical PharmaKalydecolumacaftorMedicinePhenolsRare diseasesRegulationResearchVertex Pharmaceuticals

Australian biotech survey shows advanced manufacturing heading overseas

Australian biotech survey shows advanced manufacturing heading overseas

12-06-2014

The annual Australian Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced…

AustraliaBiotechnologyBusiness FinanceBusiness FinanceChief executiveFinancialHealthcare in IndiaInnovationPoliticsProduction

China’s API industry is leading world production says new report

China’s API industry is leading world production says new report

05-06-2014

China’s chemical drug preparation industry and active pharmaceutical ingredient (API) industry recorded…

BiotechnologyBusiness FinanceChinaProduction

arGEN-X and Shire sign long term collaboration deal worth $20 million

arGEN-X and Shire sign long term collaboration deal worth $20 million

04-06-2014

Belgium-based preclinical stage biotech firm arGEN-X has entered into a long-term strategic alliance…

arGEN-XBiotechnologyBusiness FinanceEuropeHuman antibody discovery technologiesResearchShireShire Pharmaceuticals

Report shows rise in IPOs revive investments in pharma and biotech

Report shows rise in IPOs revive investments in pharma and biotech

29-05-2014

The heightened private equity and venture capital (PEVC) deal activity in the global health care industry…

BiotechnologyBusiness FinanceFinancialGlobalHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesPrivate

Ambrx and Zhejiang Hisun sign deal over cancer treatment

Ambrx and Zhejiang Hisun sign deal over cancer treatment

30-04-2014

USA-based clinical-stage biopharmaceutical company Ambrx and Chinese pharma firm Zhejiang Hisun Pharmaceutical…

AmbrxBiopharmaceuticalBiotechnologyBusiness FinanceChinaHealth Medical PharmaHealth Medical PharmaLicensingOncologyPharmaceutical industryUSA

New report finds upturn in the Swiss biotech sector in 2013

15-04-2014

The Swiss biotech sector saw increases in terms of net sales, capital investments and number of employees,…

BiotechnologyBusiness FinanceBusiness FinanceEnvironmentHelvetiiMarkets & MarketingNorthern EuropeSwitzerland

Back to top